A structured form designed to support the transition of young people with ADHD from child to adult services. It captures medical history, current status, and relevant risk factors to ensure continuity of care.

Kobus van Rensburg discusses ADHD and autism in youth, covering prevalence, diagnostic overlap, assessment strategies, comorbidity, differential traits, and emphasizes personalized, person-centred support approaches.

Prof. Raja Mukherjee provides expert insight into the Cortese et al. meta-analysis, evaluating ADHD treatment efficacy and tolerability, and discussing clinical implications for personalised care and medication strategies.

This checklist supports UK healthcare professionals in initiating Elvanse for ADHD, detailing contraindications, monitoring requirements, comorbidities, drug interactions, and patient history considerations.

This initiation checklist outlines baseline assessments, dosing schedules, and monitoring requirements for starting patients aged 6–17 on INTUNIV for ADHD, including cardiovascular, psychological, and weight-related evaluations.

The Management of Adult ADHD Pack (MAP) is an interactive digital programme that aims to help healthcare professionals further understand treatment pathways for adult patients (≥ 18 years) with ADHD.

The Treatment Optimisation Toolkit (TOT) is an interactive digital programme in which healthcare professionals can explore appropriate treatment pathways for patients with ADHD, aged 6-17 years old.

In this recording from the 15th annual Meeting of Minds conference Dr. Larry Klassen discusses how to distinguish ADHD from common psychiatric comorbidities including red flags for ADHD, assessment triggers and treatment.

Expert talk by Prof. David Nutt examining the intersection of addiction and ADHD, discussing neurobiological mechanisms, comorbidity, and treatment approaches, with clinical anecdotes highlighting diagnostic complexities, the role of dopamine, and the impact of stimulant therapy on substance use and behavioural addictions.